nomela®

Melanoma risk-assessment technology

Non-invasive screening aid to indicate the chance of melanoma in pigmented skin lesions (moles)

On-device AI by machine-learning
Single-application iPads
For use by medical professionals

Intended positioning: the clinical pathway for the management of suspect skin lesions

Applies automated edge detection to exclude surrounding skin

Cyber Security Plus certified
QMS ISO 13485 certified

The nomela® test

nomela® features

 
 

Support

Fully integrated infrastructure with easy input to electronic patient records (EPR). Connectivity, device delivery, updates, replacements
and 24-hour help-line.

Process flows

Easy integration of nomela® reports into electronic patient records. Standalone infrastructure for surveillance of diagnosis and location and regional overview of activity via real-time dashboard.

 

Contact us